re: Ann: Axiron Net Sales for the Quarter to ... The Motley Fool comp is misleading as there is some seasonality in the Q figures. Take a look at the Q results todate.
Would be interested in view on Axiron taking more share - can they get to 20% of the market (or is 14% the best they can get)? certainly looking hard at this point given Androgel was the only mkt share gainer for the Quarter.
net sales (US$m): market share (%)
2011 Q1 0 0.0%
Q2 3.2 2.0%
Q3 5.3 6.0%
Q4 15.5 9.0%
2012 Q1 16.2 11.0%
Q2 17.7 12.0%
Q3 16 12.0%
Q4 23.9 13.0%
2013 Q1 37.1 14.1%
Q2 47.1 14.0%
Q3 40.6 14.3%
Q4 53.9 14.3%
2014 Q1 39.5 14.20%
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.339M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $11.58K | 619.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 335415 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 516258 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |